Furthermore, we found that FOLFOX-Bev treatment enhanced the cytotoxicity of CD8+ T cells while impairing the functions of tumor-associated macrophages (TAMs), plasma cells, and cancer-associated fibroblasts (CAFs). Here, CD8A is linked to neoplasm.